AURO-LAMIVUDINE/ZIDOVUDINE
AURO-LAMIVUDINE/ZIDOVUDINE
Approved
DIN Number
02414414
Drug Class
Human
Market Date
Mar 3, 2014
Company
HC
auro pharma inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02414414
AIG Number0235460001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AR01 ZIDOVUDINE AND LAMIVUDINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.08.20
Health Canada Classification
ACTIVE INGREDIENTS (2)
LAMIVUDINEActive
Strength: 150 MG
Monograph: LAMIVUDINE
ZIDOVUDINEActive
Strength: 300 MG
Monograph: ZIDOVUDINE